Consistent findings across several studies have demonstrated the role of VEGF in the pathogenesis of MDS and high expression of VEGF was correlated with increased transfusion needs, overall survival, and leukemia-free survival (26–28). This evidence concerns the gene VEGFA and myelodysplastic syndrome.